These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3260689)

  • 21. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
    Tektonidou MG; Anapliotou M; Vlachoyiannopoulos P; Moutsopoulos HM
    Ann Rheum Dis; 2004 Sep; 63(9):1159-61. PubMed ID: 15308528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and serological characteristics of anti-Ro/SS-A and anti-La/SS-B negative primary Sjögren's syndrome: a comparative study.
    Bodakçi E
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1760-1767. PubMed ID: 38497858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Autoantibodies in patients with Sjögren's syndrome and their clinical significance].
    Miyawaki S
    Nihon Rinsho; 1995 Oct; 53(10):2422-8. PubMed ID: 8531349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
    Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
    J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Siögren's syndrome: anti-Ro and anti-La autoantibodies trigger apoptotic mechanism in the human salivary gland cell line, A-253.
    Lisi S; Sisto M; Scagliusi P; Mitolo V; D'Amore M
    Panminerva Med; 2007 Sep; 49(3):103-8. PubMed ID: 17912146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Autoimmune thyroid diseases and Gougerot-Sjögren syndrome].
    Sanmarco M; Heim M; Bernard D; Simonin R
    Pathol Biol (Paris); 1988 Sep; 36(7):867-70. PubMed ID: 3059267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
    Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
    J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
    Tomás S; Coll J; Reth P; Corominas JM
    Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 10 (IL-10) influences autoimmune response in primary Sjögren's syndrome and is linked to IL-10 gene polymorphism.
    Anaya JM; Correa PA; Herrera M; Eskdale J; Gallagher G
    J Rheumatol; 2002 Sep; 29(9):1874-6. PubMed ID: 12233881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjögren's syndrome and apoptosis in human salivary gland cell line A-253.
    Lisi S; Sisto M; Soleti R; Saponaro C; Scagliusi P; D'Amore M; Saccia M; Maffione AB; Mitolo V
    J Oral Pathol Med; 2007 Oct; 36(9):511-23. PubMed ID: 17850433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.
    Retamozo S; Akasbi M; Brito-Zerón P; Bosch X; Bove A; Perez-de-Lis M; Jimenez I; Soto-Cardenas MJ; Gandia M; Diaz-Lagares C; Viñas O; Siso A; Perez-Alvarez R; Yague J; Ramos-Casals M
    Clin Exp Rheumatol; 2012; 30(5):686-92. PubMed ID: 22704838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome.
    Hernández-Molina G; Leal-Alegre G; Michel-Peregrina M
    Autoimmun Rev; 2011 Jan; 10(3):123-5. PubMed ID: 20833272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical associations of autoantibodies to human muscarinic acetylcholine receptor 3(213-228) in primary Sjogren's syndrome.
    Kovács L; Marczinovits I; György A; Tóth GK; Dorgai L; Pál J; Molnár J; Pokorny G
    Rheumatology (Oxford); 2005 Aug; 44(8):1021-5. PubMed ID: 15888503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The clinical significance of disorders of humoral immunity in Sjögren's disease and syndrome].
    Kirtava ZZ
    Revmatologiia (Mosk); 1990; (4):35-41. PubMed ID: 2075353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary Sjögren's syndrome. A longitudinal study of 68 patients].
    Botsios C; Ostuni P; Sfriso P; Grava C; Andretta M; Todesco S
    Recenti Prog Med; 2001 Dec; 92(12):741-6. PubMed ID: 11822094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary diagnostic criteria for Sjögren's syndrome.
    Skopouli FN; Drosos AA; Papaioannou T; Moutsopoulos HM
    Scand J Rheumatol Suppl; 1986; 61():22-5. PubMed ID: 3473635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability and sensitivity of diagnostic tests for primary Sjögren's syndrome.
    Haga HJ; Hulten B; Bolstad AI; Ulvestad E; Jonsson R
    J Rheumatol; 1999 Mar; 26(3):604-8. PubMed ID: 10090170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
    Rihl M; Ulbricht K; Schmidt RE; Witte T
    Rheumatology (Oxford); 2009 Jul; 48(7):796-9. PubMed ID: 19433433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
    Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
    J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.